Puma Bio (PBYI) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Puma Bio Revenue Highlights

Latest Revenue (Y)

$230.47M

Latest Revenue (Q)

$56.14M

Main Segment (Y)

Product

Main Geography (Y)

Royalty

Puma Bio Revenue by Period

Puma Bio Revenue by Year

Date	Revenue	Change
2024-12-31	$230.47M	-2.19%
2023-12-31	$235.64M	3.35%
2022-12-31	$228.00M	-9.95%
2021-12-31	$253.20M	12.48%
2020-12-31	$225.10M	-17.33%
2019-12-31	$272.30M	8.49%
2018-12-31	$251.00M	806.14%
2017-12-31	$27.70M	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	-100.00%
2011-12-31	$-281.10K	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $230.47M in revenue during NA 2024, up -2.19% compared to the previous quarter, and up 84.64% compared to the same period a year ago.

Puma Bio Revenue by Quarter

Date	Revenue	Change
2024-09-30	$56.14M	19.23%
2024-06-30	$47.08M	7.58%
2024-03-31	$43.77M	-39.36%
2023-12-31	$72.18M	28.62%
2023-09-30	$56.12M	2.84%
2023-06-30	$54.57M	3.40%
2023-03-31	$52.77M	-19.67%
2022-12-31	$65.70M	15.06%
2022-09-30	$57.10M	-4.06%
2022-06-30	$59.52M	30.13%
2022-03-31	$45.74M	-17.44%
2021-12-31	$55.40M	19.80%
2021-09-30	$46.24M	-13.37%
2021-06-30	$53.38M	-45.62%
2021-03-31	$98.17M	86.63%
2020-12-31	$52.60M	3.64%
2020-09-30	$50.75M	-28.09%
2020-06-30	$70.58M	37.81%
2020-03-31	$51.22M	-18.57%
2019-12-31	$62.90M	11.52%
2019-09-30	$56.40M	4.60%
2019-06-30	$53.92M	-45.59%
2019-03-31	$99.10M	39.38%
2018-12-31	$71.10M	13.58%
2018-09-30	$62.60M	23.31%
2018-06-30	$50.77M	-23.68%
2018-03-31	$66.52M	207.94%
2017-12-31	$21.60M	255.44%
2017-09-30	$6.08M	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $56.14M in revenue during Q3 2024, up 19.23% compared to the previous quarter, and up 102.87% compared to the same period a year ago.

Puma Bio Revenue Breakdown

Puma Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 20	Dec 19	Dec 18
Product	$195.19M	$211.62M	$200.49M	-
Royalty	$35.28M	$5.68M	$391.00K	-
License	-	$2.50M	$60.25M	$50.50M

Puma Bio's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (84.69%), and Royalty (15.31%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Jun 24	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$8.19M	$24.41M	$2.69M	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
Product	$94.66M	$56.14M	$44.40M	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-
License	-	-	-	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-

Puma Bio's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (92.04%), and Royalty (7.96%).

Puma Bio Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 20	Dec 19	Dec 18
Royalty	$5.68M	$391.00K	-
License	$2.50M	$60.25M	$50.50M
Product	-	$211.62M	$200.49M

Puma Bio's latest annual revenue breakdown by geography, as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Country

Country	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
Product	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-
License	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-

Puma Bio's latest quarterly revenue breakdown by geography, as of Jun 21: Product (91.52%), Royalty (8.01%), and License (0.47%).

Puma Bio Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SRPT	Sarepta Therapeutics	$1.90B	$362.93M
PTCT	PTC Therapeutics	$806.78M	$135.42M
RARE	Ultragenyx Pharmaceutical	$560.23M	$147.03M
CHRS	Coherus BioSciences	$266.96M	$70.77M
ARVN	Arvinas	$263.40M	$102.40M
PBYI	Puma Bio	$230.47M	$56.14M
MDGL	Madrigal Pharmaceuticals	$180.13M	$62.17M
IOVA	Iovance Biotherapeutics	$164.07M	$58.55M
MGNX	MacroGenics	$149.96M	$110.71M
HRTX	Heron Therapeutics	$144.28M	$36.02M
KURA	Kura Oncology	$53.88M	-
TSVT	2seventy bio	$37.86M	$13.53M
CRNX	Crinetics Pharmaceuticals	$1.04M	-
VKTX	Viking Therapeutics	-	-
RVMD	Revolution Medicines	-	-
HEPA	Hepion Pharmaceuticals	-	-
LRMR	Larimar Therapeutics	-	-

PBYI Revenue FAQ

What is Puma Bio’s yearly revenue?

Puma Bio's yearly revenue for 2024 was $230.47M, representing a decrease of -2.19% compared to 2023. The company's yearly revenue for 2023 was $235.64M, representing an increase of 3.35% compared to 2022. PBYI's yearly revenue for 2022 was $228M, representing a decrease of -9.95% compared to 2021.

What is Puma Bio’s quarterly revenue?

Puma Bio's quarterly revenue for Q3 2024 was $56.14M, a 19.23% increase from the previous quarter (Q2 2024), and a 0.04% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $47.08M, a 7.58% increase from the previous quarter (Q1 2024), and a -13.72% decrease year-over-year (Q2 2023). PBYI's quarterly revenue for Q1 2024 was $43.77M, a -39.36% decrease from the previous quarter (Q4 2023), and a -17.07% decrease year-over-year (Q1 2023).

What is Puma Bio’s revenue growth rate?

Puma Bio's revenue growth rate for the last 3 years (2022-2024) was 1.08%, and for the last 5 years (2020-2024) was 2.38%.

What are Puma Bio’s revenue streams?

Puma Bio's revenue streams in c 24 are Product, and Royalty. Product generated $195.19M in revenue, accounting 84.69% of the company's total revenue, down -7.77% year-over-year. Royalty generated $35.28M in revenue, accounting 15.31% of the company's total revenue, up 520.94% year-over-year.

What is Puma Bio’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Puma Bio was Product. This segment made a revenue of $195.19M, representing 84.69% of the company's total revenue.